SLA congratulates Roslin Cells on their recent success with TSB funding
Released: Thursday 23rd August 2012
SLA is delighted to see Roslin Cells secure over £125 K in funding from the Biocatalyst Feasibility Competition. Roslin Cells will use this to
improve the clinical utility of umbilical cord blood donations by Ex-Vivo Expansion using Mesenchymal Stromal Cells.
For further details please contact email@example.com